Taxanes in the adjuvant treatment of breast cancer: why not yet?

Journal of the National Cancer Institute. Monographs

Volumn , Issue 30, 2001, Pages 88-95

  Piccart, M J ^a   Lohrisch, C ^a   Duchateau, L ^a   Buyse, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DRUG DERIVATIVE; PACLITAXEL; TAXOID;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; META ANALYSIS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS; UTILIZATION REVIEW;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; META-ANALYSIS; PACLITAXEL; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; TAXOIDS;

EID: 0035756540     PISSN: 10526773     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jncimonographs.a003468     Document Type: Article

References (0)